Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

Abstract

Long-term TAF treatment resulted in high rates of viral suppression, no resistance, and favorable renal and bone safety.